此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

甲状腺切除术后低钙血症

2026年9月19日 更新者:Saleh Khairy Saleh MD、Minia University

甲状腺切除术后低钙血症临床与手术预测因素的十年队列研究

This retrospective cohort study investigates predictors of postoperative hypocalcemia following thyroidectomy procedures at Minia University Hospital over a 10-year period (2014-2024). Postthyroidectomy hypocalcemia is one of the most common complications of thyroid surgery, affecting 20-50% of patients. The study aims to identify demographic, clinical, laboratory, and surgical factors associated with the development of both transient and permanent hypocalcemia. Results will inform risk stratification, patient counseling, and perioperative management strategies.

研究概览

详细说明

Hypocalcemia is a frequent complication following thyroidectomy, resulting from inadvertent parathyroid gland injury, removal, or devascularization. While most cases resolve within 6 months (transient hypocalcemia),permanent hypocalcemia occurs in 1-3% of patients and requires lifelong calcium and vitamin D supplementation, significantly impacting quality of life.

This single-center retrospective study will systematically review medical records of all patients who underwent thyroidectomy (total, subtotal, or completion) at Minia University Hospital between January 1, 2014, andDecember 31, 2024. The primary objective is to identify independent predictors of postoperative hypocalcemia using multiple logistic regression analysis.

Data extraction will include:

Demographics: age, gender, BMI Clinical factors: indication for surgery, thyroid disease type, presence of Graves' disease, substernal extension Preoperative laboratory values: calcium, vitamin D, PTH, thyroid function tests Surgical details: extent of thyroidectomy, central/lateral lymph node dissection, surgeon experience,operative time, parathyroid gland identification and autotransplantation Postoperative data: calcium levels (24h, 48h, 1 week, 6 weeks, 3 months, 6 months), PTH levels,supplementation requirements Pathology: thyroid weight, presence of parathyroid tissue in specimen, thyroiditis, malignancy The study will employ robust statistical methods including univariate analysis to screen potential predictors and multiple logistic regression to identify independent risk factors. A clinical risk prediction score will be developed and internally validated using split-sample methodology. Subgroup analyses will examine differences between transient and permanent hypocalcemia and stratify results by extent of surgery and surgeon experience.

Target sample size of 500-600 patients was calculated using G*Power to ensure adequate statistical power(>80%) .

Findings will contribute to evidence-based perioperative protocols, improved patient selection for outpatient thyroidectomy, tailored monitoring strategies, and informed decision-making regarding prophylactic calcium supplementation.

研究类型

观察性的

注册 (估计的)

600

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • Minya Governorate
      • Minya、Minya Governorate、埃及、61519

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

This retrospective cohort study will include adult patients (aged 18 years and older) who underwent a thyroidectomy procedure at Minia University Hospital, a tertiary care centre in Egypt, between January 1, 2014, and December 31, 2024. The target population consists of approximately 600 consecutive patients who meet the eligibility criteria. This includes patients with available medical records containing complete surgical and postoperative data, documented postoperative serum calcium levels, and a minimum of 6 months of follow-up or a documented outcome status. Patients will be excluded if they have preoperative hypocalcemia, pre-existing parathyroid disorders, chronic kidney disease (Stage 3 or higher), or other conditions that significantly affect calcium metabolism. The study population represents a consecutive sample of all patients meeting these criteria over the 10-year study period at this single academic center.

描述

Inclusion Criteria:

  • Adult patients aged 18 years or older at time of surgery
  • Underwent thyroidectomy at Minia University Hospital
  • Availability of medical records with complete surgical and postoperative data
  • Documented serum calcium levels measured postoperatively
  • Minimum follow-up of 6 months postoperatively or documented outcome status

Exclusion Criteria:

  • Age less than 18 years at time of surgery
  • Preoperative hypocalcemia (serum calcium <8.0 mg/dL or ionized calcium <1.0 mmol/L)
  • Pre-existing parathyroid disorders (primary hyperparathyroidism, hypoparathyroidism, secondary or tertiary hyperparathyroidism)
  • Chronic kidney disease Stage 3 or higher (estimated glomerular filtration rate <60 mL/min/1.73m²)
  • Malabsorption syndromes affecting calcium metabolism (celiac disease, inflammatory bowel disease,short bowel syndrome)
  • Concurrent planned parathyroidectomy
  • History of neck irradiation
  • Chronic use of medications significantly affecting calcium metabolism (bisphosphonates, denosumab,cinacalcet, chronic corticosteroids)
  • Incomplete medical records lacking essential data including surgical details, postoperative calcium levels,or follow-up data
  • Patients lost to follow-up before 6-month endpoint without documented outcome status

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:RETROSPECTIVE

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Incidence of Postoperative Hypocalcemia
大体时间:Within 6 months post-surgery

Development of hypocalcemia defined as:

Serum total calcium <8.0 mg/dL (2.0 mmol/L) OR Ionized calcium <1.0 mmol/L OR Symptomatic hypocalcemia (perioral numbness, paresthesias, carpopedal spasm, positive Chvostek's orTrousseau's sign) requiring calcium supplementation Measured at: 24 hours, 48 hours, 1 week, 6 weeks, 3 months, and 6 months postoperatively

Within 6 months post-surgery

次要结果测量

结果测量
措施说明
大体时间
Incidence of Transient Hypocalcemia
大体时间:Up to 6 months post-surgery

Hypocalcemia that resolves within 6 months of surgery without need for continued calcium and/or vitamin D supplementation beyond 6-month follow-up

Up to 6 months post-surgery
Incidence of Permanent Hypocalcemia
大体时间:6 months post-surgery

Hypocalcemia requiring ongoing calcium and/or vitamin D supplementation persisting beyond 6months postoperatively, indicating permanent hypoparathyroidism

6 months post-surgery
Incidence of Symptomatic Hypocalcemia
大体时间:Within 2 weeks post-surgery

Clinical manifestations of hypocalcemia including:

Neuromuscular irritability (perioral tingling, paresthesias) Tetany or carpopedal spasm Positive Chvostek's sign (facial nerve twitching) Positive Trousseau's sign (carpal spasm with blood pressure cuff inflation) Seizures (rare) Cardiac manifestations: prolonged QT interval, arrhythmias (rare)

Within 2 weeks post-surgery
Hospital Length of Stay
大体时间:From surgery to discharge, typically 2-5 days

Duration of hospitalization in days following thyroidectomy, measured from date of surgery to date of hospital discharge

From surgery to discharge, typically 2-5 days
Calcium and Vitamin D Supplementation Requirement
大体时间:Up to 6 months post-surgery

Need for oral calcium supplementation (yes/no and total daily dose in mg) Need for vitamin D supplementation (yes/no and total daily dose in IU) Duration of supplementation (days/weeks) Need for intravenous calcium administration (yes/no)

Up to 6 months post-surgery
Emergency Department Visits for Hypocalcemia
大体时间:Within 30 days post-discharge

Unplanned emergency department visits related to symptoms of hypocalcemia or complications of calcium/vitamin D therapy

Within 30 days post-discharge
Hospital Readmission Related to Hypocalcemia
大体时间:Within 30 days post-discharge

Unplanned hospital readmission related to symptomatic hypocalcemia or its complications

Within 30 days post-discharge
Postoperative Parathyroid Hormone (PTH) Level
大体时间:24 hours post-surgery

Serum intact parathyroid hormone level measured within 24 hours postoperatively (pg/mL), used as predictor of sustained hypocalcemia

24 hours post-surgery
Nadir Calcium Level
大体时间:Within 7 days post-surgery

Lowest serum calcium level (total or ionized) recorded during initial hospitalization or within first week postoperatively

Within 7 days post-surgery
Time to Calcium Normalization
大体时间:Up to 6 months post-surgery

Duration in days from surgery to sustained normalization of serum calcium levels without supplementation (for those who develop hypocalcemia)

Up to 6 months post-surgery

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Saleh K Saleh, MD、Minia University

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2014年1月1日

初级完成 (估计的)

2026年12月1日

研究完成 (估计的)

2027年1月1日

研究注册日期

首次提交

2026年2月17日

首先提交符合 QC 标准的

2026年2月17日

首次发布 (实际的)

2026年2月23日

研究记录更新

最后更新发布 (实际的)

2026年9月22日

上次提交的符合 QC 标准的更新

2026年9月19日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅